Amoxicillin

Generic Name
Amoxicillin
Brand Names
Amoxil, Augmentin, Clavulin, Moxatag, Omeclamox, Prevpac, Talicia, Voquezna 14 Day Dualpak 20;500, Voquezna 14 Day Triplepak 20;500;500
Drug Type
Small Molecule
Chemical Formula
C16H19N3O5S
CAS Number
26787-78-0
Unique Ingredient Identifier
9EM05410Q9
Background

Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972. Amoxicillin has similar activity to penicillin and ampicillin, but leads to higher serum concentrations than ampicillin.

Amoxicillin was granted FDA approval on 18 January 1974.

Indication

Amoxicillin alone is indicated to treat susceptible bacterial infections of the ear, nose, throat, genitourinary tract, skin, skin structure, and lower respiratory tract. Amoxicillin is given with calvulanic acid to treat acute bacterial sinusitis, community acquired pneumonia, lower respiratory tract infections, acute bacterial otitis media, skin and skin s...

Associated Conditions
Acute Bacterial Sinusitis (ABS), Acute Otitis Media (AOM), Bacterial Infections, Community Acquired Pneumonia (CAP), Duodenal ulcer caused by helicobacter pylori, Genitourinary tract infection, Helicobacter Pylori Infection, Lower Respiratory Tract Infection (LRTI), Peptic Ulcer With H. Pylori Infection, Sinusitis, Skin and Subcutaneous Tissue Bacterial Infections, Urinary Tract Infection, Acute, uncomplicated Gonorrhea, Ear, nose, and throat infections
Associated Therapies
-

Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

First Posted Date
2023-02-08
Last Posted Date
2023-05-15
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Target Recruit Count
855
Registration Number
NCT05718609
Locations
🇨🇳

Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China

The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication

First Posted Date
2022-12-20
Last Posted Date
2023-02-08
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
100
Registration Number
NCT05658055
Locations
🇨🇳

Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori

First Posted Date
2022-12-14
Last Posted Date
2024-11-19
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
900
Registration Number
NCT05649540
Locations
🇨🇳

Changzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu, China

🇨🇳

Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

🇨🇳

The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, Jiangsu, China

and more 10 locations

Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2022-07-25
Last Posted Date
2024-03-08
Lead Sponsor
University of California, San Francisco
Target Recruit Count
307
Registration Number
NCT05473234
Locations
🇳🇬

The Tamaika Project, Gombe, Gombe State, Nigeria

Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication

First Posted Date
2022-07-22
Last Posted Date
2024-06-13
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
914
Registration Number
NCT05469685
Locations
🇨🇳

Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China

🇨🇳

Changshu No.1 People's Hospital, Suzhou, Jiangsu, China

🇨🇳

Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

and more 7 locations

Geisinger Antibiotic Allergy Pilot Program: Assess and Address

Early Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2022-07-19
Last Posted Date
2024-04-30
Lead Sponsor
Geisinger Clinic
Target Recruit Count
100
Registration Number
NCT05464615
Locations
🇺🇸

Geisinger Community Medical Center, Scranton, Pennsylvania, United States

🇺🇸

Geisinger Wyoming Valley, Wilkes-Barre, Pennsylvania, United States

🇺🇸

Geisinger Medical Center, Danville, Pennsylvania, United States

Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis

First Posted Date
2022-07-05
Last Posted Date
2024-07-18
Lead Sponsor
University of Guarulhos
Target Recruit Count
89
Registration Number
NCT05444218
Locations
🇧🇷

University of Guarulhos, Guarulhos, São Paulo, Brazil

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

First Posted Date
2022-06-24
Last Posted Date
2024-03-27
Lead Sponsor
Shandong University
Target Recruit Count
406
Registration Number
NCT05431075
Locations
🇨🇳

Zhengzhou Central Hospital, Zhengzhou, Henan, China

🇨🇳

Qilu hosipital, Jinan, Shandong, China

🇨🇳

Taierzhuang District People's Hospital, Taierzhuang, Shandong, China

and more 3 locations

Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection

First Posted Date
2022-06-15
Last Posted Date
2023-02-16
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Target Recruit Count
393
Registration Number
NCT05419674
Locations
🇨🇳

Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China

© Copyright 2024. All Rights Reserved by MedPath